BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.3052
0.00 (0.00%)
At close: Apr 14, 2026
BioCorRx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.14 | 0.09 | 0.07 | 0.07 | 0.09 |
Cash & Short-Term Investments | 0.14 | 0.09 | 0.07 | 0.07 | 0.09 |
Cash Growth | 58.30% | 34.97% | -4.95% | -20.06% | -85.50% |
Accounts Receivable | 0.25 | - | 0 | 0.04 | 0 |
Other Receivables | 0.05 | - | 0.08 | 0.13 | 0.06 |
Receivables | 0.31 | - | 0.08 | 0.17 | 0.06 |
Inventory | 0.14 | - | - | - | - |
Prepaid Expenses | 0.23 | 0.03 | 0.04 | 0.08 | 0.08 |
Total Current Assets | 0.81 | 0.12 | 0.19 | 0.32 | 0.23 |
Property, Plant & Equipment | 0.16 | 0.22 | 0.15 | 0.35 | 0.49 |
Goodwill | 0.56 | - | - | - | - |
Other Intangible Assets | 0.56 | 0.01 | 0.01 | 0.06 | 0.06 |
Other Long-Term Assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Total Assets | 2.15 | 0.39 | 0.39 | 0.77 | 0.82 |
Accounts Payable | 4.03 | 3.02 | 2.47 | 2.01 | 1.78 |
Accrued Expenses | 2.31 | 2.54 | 2.18 | 1.57 | 1.41 |
Short-Term Debt | 1.91 | 2.54 | 1.61 | 1.29 | 1.01 |
Current Portion of Long-Term Debt | - | - | - | - | 0.03 |
Current Portion of Leases | 0.04 | 0.04 | 0.12 | 0.13 | 0.12 |
Current Unearned Revenue | - | 0.06 | - | 0.03 | 0.03 |
Other Current Liabilities | 0.01 | 0.01 | 0.05 | 0.32 | 0 |
Total Current Liabilities | 8.31 | 8.21 | 6.43 | 5.36 | 4.39 |
Long-Term Debt | 0.07 | 0.07 | 0.07 | 0.07 | 0.17 |
Long-Term Leases | 0.12 | 0.16 | 0.01 | 0.18 | 0.32 |
Long-Term Unearned Revenue | - | - | 0 | 0 | 0.04 |
Other Long-Term Liabilities | 5.18 | 4.3 | 3.82 | 3.35 | 2.87 |
Total Liabilities | 13.67 | 12.74 | 10.34 | 8.97 | 7.78 |
Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 75.28 | 70.95 | 68.15 | 66.13 | 62.99 |
Retained Earnings | -86.65 | -83.21 | -78.1 | -74.34 | -69.97 |
Comprehensive Income & Other | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Total Common Equity | -11.25 | -12.14 | -9.85 | -8.1 | -6.87 |
Minority Interest | -0.3 | -0.23 | -0.13 | -0.13 | -0.12 |
Shareholders' Equity | -11.53 | -12.36 | -9.95 | -8.2 | -6.96 |
Total Liabilities & Equity | 2.15 | 0.39 | 0.39 | 0.77 | 0.82 |
Total Debt | 2.14 | 2.81 | 1.81 | 1.68 | 1.65 |
Net Cash (Debt) | -2 | -2.72 | -1.75 | -1.61 | -1.57 |
Net Cash Per Share | -0.11 | -0.26 | -0.21 | -0.22 | -0.24 |
Filing Date Shares Outstanding | 26.4 | 16.1 | 8.82 | 7.74 | 6.95 |
Total Common Shares Outstanding | 24.49 | 13.3 | 8.67 | 7.72 | 6.7 |
Working Capital | -7.49 | -8.09 | -6.24 | -5.05 | -4.16 |
Book Value Per Share | -0.46 | -0.91 | -1.14 | -1.05 | -1.02 |
Tangible Book Value | -12.37 | -12.15 | -9.85 | -8.16 | -6.92 |
Tangible Book Value Per Share | -0.51 | -0.91 | -1.14 | -1.06 | -1.03 |
Machinery | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
Leasehold Improvements | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.